Using Deep Learning Methods to Analyze Automated Breast Ultrasound and Hand-held Ultrasound Images, to Establish a Diagnosis, Therapy Assessment and Prognosis Prediction Model of Breast Cancer.

NCT ID: NCT04270032

Last Updated: 2022-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-01

Study Completion Date

2024-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is using a deep learning method to analyze the automated breast ultrasound (ABUS) and hand-held ultrasound(HHUS) images, establish and evaluate a diagnosis, therapy assessment and prognosis prediction model of breast cancer. The model would provide important references for further early prevention, early diagnosis and personalized treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Establishing a database By collecting ABUS, HHUS and comprehensive breast images data, essential information, clinical treatment information, prognosis, and curative effect information, a complete breast image database is constructed.
2. Marking ABUS images Three doctors use a semi-automatic method to frame the lesions on the image.
3. Building the model Using the deep learning method to preprocess, analyze and train the marked images, and finally get a model diagnosis, efficacy evaluation and prognosis prediction model of breast cancer.
4. Evaluating the model 1)Self-validation: Analyze the sensitivity, AUC of the breast cancer diagnosis model and the false-positive number on each ABUS volume.

2\) Compared the sensitivity, AUC and the false-positive number with a commercial diagnosis model.

3)To test the screening and diagnostic efficacy of computer-aided diagnosis systems through prospective or retrospective studies.

4)By analyzing the size and characteristics of the lesions after neoadjuvant chemotherapy, and predicting the OS and DFS time, the therapy assessment and prognosis prediction model were evaluated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

malignant group

women with malignant lesions confirmed by pathology

ABUS and HHUS

Intervention Type DIAGNOSTIC_TEST

Using deep learning method to analyze and extract the features of automated breast ultrasound and hand-held ultrasound images

benign group

women with benign lesions confirmed by pathology or stable in follow-up \> 2 years

ABUS and HHUS

Intervention Type DIAGNOSTIC_TEST

Using deep learning method to analyze and extract the features of automated breast ultrasound and hand-held ultrasound images

normal group

women have normal images with follow up \> 2 years

ABUS and HHUS

Intervention Type DIAGNOSTIC_TEST

Using deep learning method to analyze and extract the features of automated breast ultrasound and hand-held ultrasound images

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ABUS and HHUS

Using deep learning method to analyze and extract the features of automated breast ultrasound and hand-held ultrasound images

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Female patients over 18 years old who come to the two centers for physical examination or treatment;
2. Complete basic information and image data

Exclusion Criteria

1. There is no complete ABUS and HHUS images data;
2. The image quality is poor;
3. In multifocal breast cancer, the correlation between the tumor in the image and the postoperative pathological examination is uncertain.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Bundang Hospital

OTHER

Sponsor Role collaborator

Xidian University

OTHER

Sponsor Role collaborator

Shenzhen University

OTHER

Sponsor Role collaborator

The First Affiliated Hospital of the Fourth Military Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Song Hongping

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hongping Song, MD

Role: PRINCIPAL_INVESTIGATOR

Xijing hospital of The fourth military medical university

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The First Affiliated Hospital of Fourth Military Medical University

Xi'an, Shaanxi, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hongping Song, MD

Role: CONTACT

86 029 84771663

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

hongping song, Ph.D

Role: primary

+86-29-84771663

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AI-Breast-US

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.